Digital Marketing Trends in Hepatocellular Carcinoma
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Merck & Co.’s Keytruda com achieved the highest traffic across US hepatocellular carcinoma (HCC) patient sites, with 2.1 million visits from August 2021 to July 2022. This was followed by Bristol Myers Squibb’s (BMS) Opdivo.com (1.2 million visits) and Genentech’s Tecentriq com (497,000 visits). The highest proportion of traffic to these sites originated from direct sources, followed by organic and referral traffic.
The digital marketing trends in hepatocellular carcinoma research report will help to understand the digital marketing competitive landscape in HCC, with a view of leading patient and HCP branded assets across different regions. The report also offers information on what tactics pharma companies are using to drive traffic to their HCC branded assets for patients and HCPs, such as DDA and paid SEO.
Major US Patient Branded Websites for Hepatocellular Carcinoma
The major US patient-branded websites for Hepatocellular Carcinoma are Keytruda.com, Opdivo.com, Tecentriq.com, Cabometyx.com, Cyramza.com, and Lenvima.com. Merck & Co’s Keytruda.com achieved the highest traffic across Hepatocellular Carcinoma patient sites in the US from August 2021 to July 2022.
Total Traffic Engagement in Hepatocellular Carcinoma, by the US Patient-Branded Websites
For more insights on total traffic engagement of the US patient branded websites, download a free report sample
Major US HCP Branded Websites for Hepatocellular Carcinoma
The major US HCP-branded websites for Hepatocellular Carcinoma are Keytrudahcp.com, Tecentriqhcp.com, Cabometyxhcp.com, Opdivohcp.com, and Nexavar.com. Merck & Co’s Keytrudahcp.com had the highest traffic among top Hepatocellular Carcinoma websites for HCPs in the US between August 2021 to July 2022.
Total Traffic Engagement in Hepatocellular Carcinoma, by the US HCP Branded Websites
For more insights on total traffic engagement of the US HCP branded websites, download a free report sample
US Patient-Branded Websites DDA Spend and Paid SEO for Hepatocellular Carcinoma
BMS spent the most on DDA for Opdivo.com between August 2021 to July 2022, followed by Merck Co for Keytruda.com. The top publisher of ads across the 12 months was Google DV360, followed by Google Display Network, and Direct Buy.
Total DDA Spend for Hepatocellular Carcinoma, by Branded US HCC Patient Sites
For more insights on DDA spending of branded US HCC patient sites, download a free report sample
US HCP Branded Websites DDA Spend and Paid SEO for Hepatocellular Carcinoma
Merck & Co’s Keytrudahcp.com and Eisai Co.’s Lenvima.com were the only HCP sites where DDA spending was detected. Keytrudahcp.com was supported by the most paid SEO keywords, followed by Tecentriq-hcp.com.
Total DDA Spend for Hepatocellular Carcinoma, by Branded US HCP Sites
For more insights on DDA spending of branded US HCP sites, download a free report sample
Top Pharma US Social Media Channels Related to HCC
The top pharma US social media networks related to HCC are Twitter and Facebook. Between August 2021 to July 2022, 40 posts related to HCC by pharma in the US were detected. Most of these posts were from the Eisai US Twitter, Exelixis Twitter, Exelixis Facebook, and AstraZenecaUS Twitter accounts.
Top Pharma EUCAN Social Media Channels Related to HCC
Like the US, several pharma companies have developed apps for Hepatocellular Carcinoma patients in EUCAN countries. Between August 2021 and July 2022 20 posts related to HCC were detected by pharma in EUCAN. Most of these posts were from Bayer Pharmaceuticals Twitter, MSDsalute Twitter, Roche Canada Twitter, and Roche YouTube accounts.
Hepatocellular Carcinoma Digital Marketing Report Overview
Major US Patient-Branded Websites | Keytruda.com, Opdivo.com, Tecentriq.com, Cabometyx.com, Cyramza.com and Lenvima.com |
Major US HCP Branded Websites | Keytrudahcp.com, Tecentriqhcp.com, Cabometyxhcp.com, Opdivohcp.com and Nexavar.com |
Top Pharma US Social Media Accounts | Eisai US Twitter, Exelixis Twitter, Exelixis Facebook, and AstraZenecaUS Twitter |
Top Pharma EUCAN Social Media Accounts | Bayer Pharmaceuticals Twitter, MSDsalute Twitter, Roche Canada Twitter, and Roche YouTube |
Scope
- This report assesses key digital marketing metrics of pharma assets in HCC, including branded websites for patients and HCPs, mobile apps, and social media accounts.
- Metrics include website traffic volume, engagement, source, DDA, paid SEO, and social media post interaction.
- Countries include the US, 4EU (Italy, France, Germany, and Spain), the UK, and Canada (EUCAN).
Reasons to Buy
- Understand the digital marketing competitive landscape in HCC, to lead patient and HCP branded assets across different regions.
- See what tactics pharma companies are using to drive traffic to their HCC branded assets for patients and HCPs, such as DDA and paid SEO.
- Understand what sources of website traffic are generating the most visits to these assets, such as paid SEO, social media, or organic searches.
- Compare top branded assets for patients by how they address and support different patient needs.
- See what pharma social media accounts in HCC are the most active and achieving the most engagement.
Table of Contents
Frequently asked questions
-
What are the major US patient-branded websites for Hepatocellular Carcinoma?
The major US patient-branded websites for Hepatocellular Carcinoma are Keytruda.com, Opdivo.com, Tecentriq.com, Cabometyx.com, Cyramza.com, and Lenvima.com
-
What are the major US HCP branded websites for Hepatocellular Carcinoma?
The major US HCP-branded websites for Hepatocellular Carcinoma are Keytrudahcp.com, Tecentriqhcp.com, Cabometyxhcp.com, Opdivohcp.com, and Nexavar.com.
-
What are the top pharma US social media channels for Hepatocellular Carcinoma?
The top pharma US social media networks related to HCC are Eisai US Twitter, Exelixis Twitter, Exelixis Facebook, and AstraZenecaUS Twitter.
-
What are the top pharma EUCAN social media channels for Hepatocellular Carcinoma?
Some of the top pharma EUCAN social media channels for Hepatocellular Carcinoma are Bayer Pharmaceuticals Twitter, MSDsalute Twitter, Roche Canada Twitter, and Roche YouTube.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.